Education
About Us
Working with TipRanks
Follow Us
Advicenne SA (FR:ALDVI)
FRANKFURT:ALDVI
ALDVI Stock Chart & Stats
€1.72
€0.01(0.70%)
At close: 4:00 PM EST
€1.72
€0.01(0.70%)
Day’s Range― - ―
52-Week Range€1.10 - €2.20
Previous CloseN/A
Volume979.00
Average Volume (3M)26.23K
Market Cap
€26.06M
Enterprise Value€35.19M
Total Cash (Recent Filing)€515.00K
Total Debt (Recent Filing)€18.67M
Price to Earnings (P/E)―
Beta0.17
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.40
Shares Outstanding14,609,619
10 Day Avg. Volume23,481
30 Day Avg. Volume26,231
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)-1.26
Price to Sales (P/S)4.83
P/FCF Ratio-28.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.42
Revenue Forecast (FY)€4.88M
Advicenne SA News
ALDVI FAQ
What was Advicenne SA’s price range in the past 12 months?
Advicenne SA lowest stock price was €1.10 and its highest was €2.19 in the past 12 months.
What is Advicenne SA’s market cap?
Advicenne SA’s market cap is €26.06M.
When is Advicenne SA’s upcoming earnings report date?
Advicenne SA’s upcoming earnings report date is Mar 26, 2026 which is in 87 days.
How were Advicenne SA’s earnings last quarter?
Advicenne SA released its earnings results on Sep 19, 2025. The company reported -€0.4 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.4.
Is Advicenne SA overvalued?
According to Wall Street analysts Advicenne SA’s price is currently Overvalued.
Does Advicenne SA pay dividends?
Advicenne SA does not currently pay dividends.
What is Advicenne SA’s EPS estimate?
Advicenne SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Advicenne SA have?
Advicenne SA has 14,609,619 shares outstanding.
What happened to Advicenne SA’s price movement after its last earnings report?
Advicenne SA reported an EPS of -€0.4 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.09%.
Which hedge fund is a major shareholder of Advicenne SA?
Currently, no hedge funds are holding shares in FR:ALDVI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Advicenne SA
Advicenne SA (ALDVI) is a biopharmaceutical company focused on developing innovative therapies for rare diseases, particularly in the field of renal disorders. The company specializes in the research, development, and commercialization of its proprietary drug formulations, aiming to address unmet medical needs. Advicenne's core product is ADV7103, a treatment designed for patients with distal renal tubular acidosis, which underscores their commitment to improving patient outcomes in niche therapeutic areas.
Technical Analysis
Nicox SA
―
GenSight Biologics SA
―
Valbiotis SA
―
NFL Biosciences SA
―
Plant Advanced Technologies SA
―